<code id='072C1084AE'></code><style id='072C1084AE'></style>
    • <acronym id='072C1084AE'></acronym>
      <center id='072C1084AE'><center id='072C1084AE'><tfoot id='072C1084AE'></tfoot></center><abbr id='072C1084AE'><dir id='072C1084AE'><tfoot id='072C1084AE'></tfoot><noframes id='072C1084AE'>

    • <optgroup id='072C1084AE'><strike id='072C1084AE'><sup id='072C1084AE'></sup></strike><code id='072C1084AE'></code></optgroup>
        1. <b id='072C1084AE'><label id='072C1084AE'><select id='072C1084AE'><dt id='072C1084AE'><span id='072C1084AE'></span></dt></select></label></b><u id='072C1084AE'></u>
          <i id='072C1084AE'><strike id='072C1084AE'><tt id='072C1084AE'><pre id='072C1084AE'></pre></tt></strike></i>

          hotspot

          hotspot

          author:knowledge    Page View:877
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Apple is now the first public company to be valued at $3 trillion
          Apple is now the first public company to be valued at $3 trillion

          6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

          read more
          Boston Scientific acquires urology company Axonics for $3.7 billion
          Boston Scientific acquires urology company Axonics for $3.7 billion

          BostonScientificisgrowingitsurologyportfoliowiththeAxonicsacquisition.StevenSenne/APBostonScientific

          read more
          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more

          Latigo launches with $135 million for Vertex

          DesmondPadhi,PharmD,interimCEO,Latigo(center),withLatigoboardchairNancyStagliano(left)andWestlakeVil